KDP
Keurig Dr Pepper Inc. NASDAQ Listed May 7, 2008$28.52
Mkt Cap $38.8B
52w Low $24.88
33.0% of range
52w High $35.94
50d MA $27.47
200d MA $28.42
P/E (TTM)
19.0x
EV/EBITDA
12.7x
P/B
1.6x
Debt/Equity
0.6x
ROE
7.2%
P/FCF
25.3x
RSI (14)
—
ATR (14)
—
Beta
0.36
50d MA
$27.47
200d MA
$28.42
Avg Volume
11.3M
Keurig Dr Pepper Inc. operates as a beverage company in the United States and internationally. It operates through Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages segments. The Coffee Systems segment manufactures and distributes various finished goods related to its coffee systems, K-Cup pods, and brewers, as well as specialty coffee. This segment sells its brewers through third-party distributors and retail partners, as well as through its website at keurig.com. The Packaged Beverages segment engages in the manufacture and distribution of packaged beverages of its brands; contract manufacturing of various private label and emerging brand beverages; and distribution of packaged beverages for its partner brands. The Beverage Concentrates segment manufactures and sells beverage concentrates primarily under the Dr Pepper, Canada Dry, A&W, 7UP, Sunkist, Squirt, Big Red, RC Cola, Vernors, Snapple, Mott's, Bai, Hawaiian Punch, Clamato, Yoo-Hoo, Core, ReaLemon, evian, Vita Coco, and Mr and Mrs T mixers brands. This segment also manufactures beverage concentrates into syrup. The Latin America Beverages segment manufactures and distributes carbonated mineral water, flavored carbonated soft drinks, bottled water, and vegetable juice products under the Peñafiel, Clamato, Squirt, Dr Pepper, Crush, and Aguafiel brands. The company serves retailers, bottlers and distributors, restaurants, hotel chains, office coffee distributors, and end-use consumers. Keurig Dr Pepper Inc. was founded in 1981 and is headquartered in Burlington, Massachusetts.
6425 Hall of Fame Lane · Frisco, TX 75034 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | AMC | 0.37 | 0.39 | +4.7% | 28.53 | +0.0% | +2.4% | -1.3% | +0.9% | +1.4% | +3.0% | — |
| Feb 24, 2026 | AMC | 0.59 | 0.60 | +1.9% | 31.03 | -0.1% | -2.8% | -2.3% | -2.4% | -3.4% | -4.7% | — |
| Oct 27, 2025 | AMC | 0.54 | 0.54 | +0.6% | 29.23 | -0.7% | -1.3% | -7.1% | -5.3% | -7.1% | -8.9% | — |
| Jul 24, 2025 | AMC | 0.49 | 0.49 | +1.0% | 33.57 | -0.4% | -0.9% | -1.8% | +0.8% | +0.7% | -2.7% | — |
| Apr 24, 2025 | AMC | 0.38 | 0.42 | +9.8% | 34.46 | +0.9% | -0.2% | -1.2% | -0.7% | +0.4% | -1.2% | — |
| Feb 25, 2025 | AMC | 0.57 | 0.58 | +1.6% | 34.94 | -0.6% | -3.4% | -3.8% | -4.1% | -2.3% | -3.8% | — |
| Oct 24, 2024 | AMC | 0.51 | 0.51 | +0.0% | 34.94 | +0.2% | -1.0% | -3.1% | -5.9% | -5.6% | -5.7% | — |
| Jul 25, 2024 | AMC | 0.45 | 0.45 | +0.0% | 33.21 | -0.0% | +1.6% | +2.9% | +2.7% | +3.2% | +4.1% | — |
| Apr 25, 2024 | AMC | 0.35 | 0.38 | +8.6% | 33.84 | -1.0% | -0.4% | -0.4% | -0.4% | -1.5% | -0.8% | — |
| Feb 22, 2024 | AMC | 0.54 | 0.55 | +1.9% | 30.37 | +0.3% | -0.6% | -2.9% | -2.9% | -1.1% | -1.5% | — |
| Oct 26, 2023 | AMC | 0.47 | 0.48 | +2.1% | 29.51 | -0.5% | +1.2% | +1.7% | +2.8% | +3.2% | +4.6% | — |
| Jul 27, 2023 | AMC | 0.40 | 0.42 | +5.0% | 33.76 | +0.6% | +0.5% | +0.7% | +1.1% | +2.1% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $29.22 | $29.05 | -0.6% | -3.7% | -1.5% | -1.0% | +0.6% | -0.4% |
| Apr 24 | UBS | Maintains | Buy → Buy | — | $28.53 | $28.53 | +0.0% | +2.4% | -1.3% | +0.9% | +1.4% | +3.0% |
| Apr 24 | JP Morgan | Maintains | Overweight → Overweight | — | $28.53 | $28.53 | +0.0% | +2.4% | -1.3% | +0.9% | +1.4% | +3.0% |
| Apr 24 | Evercore ISI | Maintains | In Line → In Line | — | $28.53 | $28.53 | +0.0% | +2.4% | -1.3% | +0.9% | +1.4% | +3.0% |
| Apr 22 | BNP Paribas | Upgrade | Underperform → Neutral | — | $26.44 | $26.65 | +0.8% | +0.4% | +7.9% | +10.5% | +6.5% | +8.9% |
| Apr 22 | BNP Paribas Exane | Upgrade | Underperform → Neutral | $28 | $26.44 | $26.65 | +0.8% | +0.4% | +7.9% | +10.5% | +6.5% | +8.9% |
| Apr 16 | JP Morgan | Maintains | Overweight → Overweight | — | $26.00 | $25.94 | -0.2% | +0.2% | +2.0% | +1.9% | +1.7% | +2.1% |
| Apr 15 | Citigroup | Maintains | Buy → Buy | — | $26.02 | $25.87 | -0.6% | -0.1% | +0.1% | +2.0% | +1.8% | +1.6% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.04 | $25.81 | -0.9% | -0.1% | -0.2% | +0.0% | +1.9% | +1.8% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $25.47 | $25.60 | +0.5% | +1.5% | +3.7% | +4.3% | +2.2% | +2.2% |
| Apr 7 | UBS | Maintains | Buy → Buy | — | $25.70 | $25.70 | +0.0% | -0.9% | +0.5% | +2.8% | +3.4% | +1.3% |
| Mar 30 | Deutsche Bank | Maintains | Hold → Hold | — | $26.23 | $26.28 | +0.2% | +0.8% | +0.4% | -2.1% | -3.5% | -2.0% |
| Feb 26 | Barclays | Maintains | Equal Weight → Equal Weight | — | $30.15 | $30.34 | +0.6% | +0.6% | +0.4% | -0.6% | -1.9% | -4.2% |
| Feb 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $31.03 | $30.99 | -0.1% | -2.8% | -2.3% | -2.4% | -3.4% | -4.7% |
| Dec 17 | Jefferies | Downgrade | Buy → Hold | — | $28.59 | $28.50 | -0.3% | -1.9% | -1.7% | -2.4% | -1.2% | -2.4% |
| Dec 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $29.51 | $29.36 | -0.5% | -0.9% | -3.1% | -4.9% | -4.8% | -5.5% |
| Oct 28 | Wells Fargo | Maintains | Overweight → Overweight | — | $29.23 | $29.02 | -0.7% | -1.3% | -7.1% | -5.3% | -7.1% | -8.9% |
| Oct 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $29.23 | $29.02 | -0.7% | -1.3% | -7.1% | -5.3% | -7.1% | -8.9% |
| Oct 20 | JP Morgan | Maintains | Overweight → Overweight | — | $28.03 | $27.99 | -0.1% | -1.0% | -1.3% | -2.3% | -1.7% | -3.1% |
| Oct 8 | BofA Securities | Maintains | Buy → Buy | — | $25.33 | $25.29 | -0.2% | +1.0% | +2.1% | +1.9% | +4.3% | +5.4% |
| Oct 2 | Goldman Sachs | Maintains | Neutral → Neutral | — | $25.60 | $25.56 | -0.2% | +0.5% | +0.9% | -1.2% | -1.1% | -0.1% |
| Sep 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $26.25 | $26.39 | +0.5% | -1.9% | -2.9% | -2.2% | -2.8% | -2.5% |
| Sep 24 | Barclays | Downgrade | Overweight → Equal Weight | — | $26.50 | $26.20 | -1.1% | -0.9% | -2.8% | -3.8% | -3.1% | -3.7% |
| Sep 22 | BNP Paribas | Downgrade | Neutral → Underperform | — | $27.11 | $26.75 | -1.3% | -4.3% | -2.3% | -3.2% | -5.0% | -5.9% |
| Sep 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $26.96 | $27.02 | +0.2% | +1.1% | +0.9% | +0.6% | -3.7% | -1.7% |
| Sep 16 | Citigroup | Maintains | Buy → Buy | — | $26.75 | $26.74 | -0.0% | +0.8% | +1.9% | +1.7% | +1.3% | -3.0% |
| Aug 27 | UBS | Maintains | Buy → Buy | — | $28.95 | $29.00 | +0.2% | +2.7% | +1.2% | +0.5% | -0.1% | +0.5% |
| Aug 26 | Deutsche Bank | Maintains | Buy → Buy | — | $31.10 | $31.00 | -0.3% | -6.9% | -4.4% | -5.8% | -6.5% | -7.0% |
| Aug 26 | HSBC | Downgrade | Buy → Hold | — | $31.10 | $31.00 | -0.3% | -6.9% | -4.4% | -5.8% | -6.5% | -7.0% |
| Jul 28 | Barclays | Maintains | Overweight → Overweight | — | $33.27 | $33.10 | -0.5% | -0.9% | +1.7% | +1.7% | -1.9% | +0.2% |
| Jul 17 | UBS | Maintains | Buy → Buy | — | $33.21 | $33.22 | +0.0% | +2.0% | +1.0% | +0.3% | +1.7% | +0.9% |
| Jul 17 | JP Morgan | Maintains | Overweight → Overweight | — | $33.21 | $33.22 | +0.0% | +2.0% | +1.0% | +0.3% | +1.7% | +0.9% |
| Jun 27 | Barclays | Maintains | Overweight → Overweight | — | $33.04 | $32.84 | -0.6% | -0.6% | +0.1% | +1.6% | +2.4% | +2.3% |
| Apr 28 | Barclays | Maintains | Overweight → Overweight | — | $34.40 | $34.50 | +0.3% | -1.0% | -0.5% | +0.6% | -1.0% | +0.0% |
| Apr 25 | HSBC | Upgrade | Hold → Buy | — | $34.46 | $34.76 | +0.9% | -0.2% | -1.2% | -0.7% | +0.4% | -1.2% |
| Apr 22 | RBC Capital | Maintains | Outperform → Outperform | — | $35.31 | $35.53 | +0.6% | +0.5% | -0.3% | -2.4% | -2.6% | -3.6% |
| Apr 17 | UBS | Maintains | Buy → Buy | — | $35.11 | $35.23 | +0.3% | +0.8% | +0.6% | +1.1% | +0.2% | -1.9% |
| Apr 9 | Piper Sandler | Upgrade | Neutral → Overweight | — | $33.57 | $33.67 | +0.3% | +3.3% | +3.5% | +4.7% | +6.4% | +5.4% |
| Apr 1 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $34.22 | $35.00 | +2.3% | +2.2% | +2.7% | +4.1% | -1.2% | -1.8% |
| Feb 27 | Barclays | Maintains | Overweight → Overweight | — | $33.74 | $32.80 | -2.8% | -0.4% | -0.7% | +1.2% | -0.4% | -1.3% |
| Feb 26 | JP Morgan | Maintains | Overweight → Overweight | — | $34.94 | $34.74 | -0.6% | -3.4% | -3.8% | -4.1% | -2.3% | -3.8% |
| Feb 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $34.94 | $34.74 | -0.6% | -3.4% | -3.8% | -4.1% | -2.3% | -3.8% |
| Jan 17 | Barclays | Maintains | Overweight → Overweight | — | $31.28 | $31.59 | +1.0% | +1.1% | +1.4% | +0.7% | -0.7% | -0.4% |
| Jan 16 | UBS | Maintains | Buy → Buy | — | $30.97 | $31.00 | +0.1% | +1.0% | +2.1% | +2.4% | +1.7% | +0.3% |
| Jan 8 | TD Cowen | Maintains | Hold → Hold | — | $30.68 | $30.72 | +0.1% | +1.4% | -1.0% | +0.3% | +1.5% | +0.9% |
| Jan 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $31.08 | $31.00 | -0.3% | -1.3% | +0.1% | -2.3% | -1.0% | +0.2% |
| Dec 12 | Deutsche Bank | Upgrade | Hold → Buy | — | $33.26 | $33.75 | +1.5% | +1.7% | +0.9% | -0.4% | -0.7% | -2.2% |
| Oct 28 | Barclays | Maintains | Overweight → Overweight | — | $34.58 | $34.94 | +1.0% | -2.1% | -4.9% | -4.6% | -4.7% | -5.1% |
| Oct 25 | JP Morgan | Maintains | Overweight → Overweight | — | $34.94 | $35.00 | +0.2% | -1.0% | -3.1% | -5.9% | -5.6% | -5.7% |
| Oct 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $34.94 | $35.00 | +0.2% | -1.0% | -3.1% | -5.9% | -5.6% | -5.7% |
No insider trades available.
8-K
Keurig Dr Pepper Inc. -- 8-K Filing
Keurig Dr Pepper completed its acquisition of JDE Peet's and reaffirmed full-year 2026 guidance, signaling management confidence despite integrating the coffee company into its beverage portfolio.
Apr 23
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Governance / Corporate
Apollo Global Management and Keurig Dr Pepper granted registration rights to a $4 billion investor, potentially diluting existing shareholders while providing liquidity to the new investor.
Apr 1
8-K
Unknown — 8-K Filing
KDP faces potential forced redemption of Euro Notes if its JDE Peet's acquisition doesn't close by February 2027, creating financial risk and signaling deal completion uncertainty that could pressure the stock.
Mar 26
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Keurig Dr Pepper's acquisition of JDE Peet's will increase debt complexity and guarantee obligations, potentially raising financial risk and interest costs that could pressure future cash flows and shareholder returns.
Mar 12
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Keurig Dr Pepper's new material agreement with Microsoft likely involves cloud infrastructure or AI technology partnership, potentially enhancing operational efficiency and supporting digital transformation that could improve margins and competitive positioning.
Mar 10
8-K
Keurig Dr Pepper Inc. -- 8-K Filing
Keurig Dr Pepper projects double-digit adjusted EPS growth for 2026 bolstered by JDE Peet's contributions, while transitioning board chair duties from Bob Gamgort to Pamela Patsley.
Feb 24
8-K · 1.01
!! High
Keurig Dr Pepper Inc. -- 8-K 1.01: Material Agreement
Keurig Dr Pepper agreed to a $4.0 billion transaction, which could signal major strategic restructuring or asset sales affecting both APO and KDP shareholder value.
Feb 23
8-K · 5.02
!!! Very High
Keurig Dr Pepper Inc. -- 8-K 5.02: Executive Change
Keurig Dr Pepper added William Newlands and Amie Thuener to its board of directors effective March 2, 2026, expanding governance leadership.
Feb 12
8-K · 8.01
!! High
Keurig Dr Pepper Inc. -- 8-K 8.01: Material Event / Announcement
Keurig Dr Pepper will distribute its regular quarterly dividend to shareholders on April 10, 2026, providing income returns to investors holding stock as of March 27, 2026.
Feb 4
Data updated apr 25, 2026 5:17pm
· Source: massive.com